Skip to Main Content

Author Details

Lon S Schneider
Keck School of Medicine (EJ, University of Southern California
1983
371
81
PMIDPaper TitleJournal TitlePublished Year
37827916Association Between Self- and Proxy-Reported Depression and Quality of Life in Mild-Moderate Alzheimer's Disease.Am J Geriatr Psychiatry2024
36640403The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents.World Psychiatry2023
37966291What the Gantenerumab Trials Teach Us about Alzheimer's Treatment.N Engl J Med2023
35416404The small HDL particle hypothesis of Alzheimer's disease.Alzheimers Dement2023
37173791A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter.Transl Neurodegener2023
37168087The relationship of history of psychiatric and substance use disorders on risk of dementia among racial and ethnic groups in the United States.Front Psychiatry2023
37461624Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies <i>LRRC4C, LHX5-AS1</i> and nominates ancestry-specific loci <i>PTPRK</i> , <i>GRB14</i> , and <i>KIAA0825</i> as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium.medRxiv2023
36911358Reliability of the NACC Telephone-administered Neuropsychological Battery (T-cog) and Montreal Cognitive Assessment for participants in the USC ADRC.Alzheimers Dement (Amst)2023
34590409Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria.Alzheimers Dement2022
35587314The Current Landscape of Prevention Trials in Dementia.Neurotherapeutics2022
35404287Making the Case for Accelerated Withdrawal of Aducanumab.J Alzheimers Dis2022
35542997A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer's Disease.J Prev Alzheimers Dis2022
35542990Editorial: Aducanumab Trials EMERGE But Don't ENGAGE.J Prev Alzheimers Dis2022
35821792Nutrition state of science and dementia prevention: recommendations of the Nutrition for Dementia Prevention Working Group.Lancet Healthy Longev2022
35415211Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease.Alzheimers Dement (N Y)2022
35921393The Safety of Pimavanserin for Parkinson's Disease and Efforts to Reduce Antipsychotics for People With Dementia.Am J Psychiatry2022
36120786High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.J Alzheimers Dis2022
36281666Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial.J Prev Alzheimers Dis2022
35310526Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes.Alzheimers Dement (N Y)2022
35142024Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race.Alzheimers Dement2022
34647685Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon-like peptide-1 receptor agonists.Alzheimers Dement2022
34590417Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report.Alzheimers Dement2022
34087114The need to show minimum clinically important differences in Alzheimer's disease trials.Lancet Psychiatry2021
33602371The efficacy of antidepressant medication and interpersonal psychotherapy for adult acute-phase depression: study protocol of a systematic review and meta-analysis of individual participant data.BJPsych Open2021
33486003Early neuroinflammation is associated with lower amyloid and tau levels in cognitively normal older adults.Brain Behav Immun2021
33674360Value-Generating Exploratory Trials in Neurodegenerative Dementias.Neurology2021
33559354Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.Alzheimers Dement2021
34930444Impact of potential modifications to Alzheimer's disease clinical trials in response to disruption by COVID-19: a simulation study.Alzheimers Res Ther2021
34505023High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis.EClinicalMedicine2021
34151810Soluble Amyloid-β Consumption in Alzheimer's Disease.J Alzheimers Dis2021
33933666Development of novel measures for Alzheimer's disease prevention trials (NoMAD).Contemp Clin Trials2021
33933186Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.Lancet Neurol2021
31567873Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.Menopause2020
32084191Using practice effects for targeted trials or sub-group analysis in Alzheimer's disease: How practice effects predict change over time.PLoS One2020
33344752Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial.Alzheimers Dement (N Y)2020
33046556Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid.J Neurosci2020
33098796Antipsychotic prescribing to people with dementia during COVID-19.Lancet Neurol2020
32690472Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial.EBioMedicine2020
32738937Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.Lancet2020
32122400The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.Alzheimers Res Ther2020
32301266A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid.Alzheimers Dement2020
32463075Commentary: The EU/US Task Force's Future for Anti-Amyloid Trials: Faites Vos Jeux.J Prev Alzheimers Dis2020
32376954APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.Nature2020
32432156Response to peer commentaries: Composite cognitive and functional measures for early stage Alzheimer's disease trials.Alzheimers Dement (Amst)2020
32432155Composite cognitive and functional measures for early stage Alzheimer's disease trials.Alzheimers Dement (Amst)2020
32538844Progression of Alzheimer's Disease by Self-Reported Cancer History in the Alzheimer's Disease Neuroimaging Initiative.J Alzheimers Dis2020
30642436Vascular dysfunction-The disregarded partner of Alzheimer's disease.Alzheimers Dement2019
31492718Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial.Neurology2019
31231784Treatment Options for Agitation in Dementia.Curr Treat Options Neurol2019
31282954Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial.JAMA Neurol2019
  • 1 - 50 of 371

Recommended Authors

George Vradenburg
Career Start Year 2013
Number of shared co-authors 17
Scott A Sperling
Center for Neurological Restoration, Cleveland Clinic
Career Start Year 2013
Number of shared co-authors 0
Danielle Newby
Warneford Hospital, University of Oxford
Career Start Year 2012
Number of shared co-authors 3
Sang Joon Son
Ajou University School of Medicine
Career Start Year 2011
Number of shared co-authors 1
Kelly L Sloane
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 4
Rita Khoury
Saint Louis University
Career Start Year 2009
Number of shared co-authors 0
Deniz Erten-Lyons
Oregon Health and Science University
Career Start Year 2006
Number of shared co-authors 16
Richard S Isaacson
Weill Cornell Medical College
Career Start Year 2005
Number of shared co-authors 11
Huali Wang
Peking University, Institute of Mental Health (Sixth Hospital)
Career Start Year 2004
Number of shared co-authors 15
Jordan J Elm
Medical University of South Carolina
Career Start Year 2002
Number of shared co-authors 3
Yuriko Katsumata
University of Kentucky
Career Start Year 2002
Number of shared co-authors 21
Moon Ho Park
Korea University Ansan Hospital, Korea University College of Medicine
Career Start Year 2001
Number of shared co-authors 0
Jennifer S Hui
Keck School of Medicine of USC
Career Start Year 2001
Number of shared co-authors 1
James E Galvin
Comprehensive Center for Brain Health, University of Miami Miller School of Medicine
Career Start Year 1997
Number of shared co-authors 50
Ruth O'Hara
Stanford University School of Medicine
Career Start Year 1995
Number of shared co-authors 16
Patricia W Slattum
Virginia Commonwealth University
Career Start Year 1995
Number of shared co-authors 1
Balwinder Singh
Mayo Clinic
Career Start Year 1994
Number of shared co-authors 10
David S Geldmacher
University of Alabama at Birmingham
Career Start Year 1993
Number of shared co-authors 21
Henry Michael Arrighi
Janssen Pharmaceuticals Research & Development
Career Start Year 1990
Number of shared co-authors 9
George Webster Ross
Pacific Health Research and Education Institute
Career Start Year 1989
Number of shared co-authors 8
Carol A Manning
University of Virginia
Career Start Year 1988
Number of shared co-authors 10
Timothy G Lesnick
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 34
Paul E Schulz
The University of Texas Health Science Center at Houston, McGovern Medical School
Career Start Year 1988
Number of shared co-authors 5
Walter A Rocca
Mayo Clinic
Career Start Year 1985
Number of shared co-authors 18
Mya C Schiess
McGovern Medical School at UTHealth
Career Start Year 1982
Number of shared co-authors 3
Bruce M Cohen
Harvard Medical School
Career Start Year 1979
Number of shared co-authors 12
Jason Brandt
The Johns Hopkins University School of Medicine
Career Start Year 1979
Number of shared co-authors 27
Cameron G Swift
King's College London
Career Start Year 1978
Number of shared co-authors 0
Joseph J Locascio
Harvard Medical School, Massachusetts General Hospital
Career Start Year 1975
Number of shared co-authors 15
Igor Grant
University of California San Diego
Career Start Year 1973
Number of shared co-authors 20

Collaborators

Pierre N Tariot
Banner Alzheimer's Institute
Co-authored papers 34
Anton P Porsteinsson
University of Rochester, University of Rochester Medical Center
Co-authored papers 29
Jacobo E Mintzer
Inc., Medical University of South Carolina
Co-authored papers 25
Paul S Aisen
Alzheimer's Therapeutic Research Institute, University of Southern California
Co-authored papers 25
Ronald G Thomas
University of California
Co-authored papers 21
Peter V Rabins
Johns Hopkins School of Medicine
Co-authored papers 21
Ronald C Petersen
Mayo Clinic Rochester
Co-authored papers 18
Rachelle S Doody
F. Hoffmann-La Roche Ltd
Co-authored papers 17
John C Morris
Washington University School of Medicine
Co-authored papers 17
Douglas Galasko
Co-authored papers 16
Martin R Farlow
Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM)
Co-authored papers 15
Howard H Feldman
University of California San Diego
Co-authored papers 15
Jerome A Yesavage
Stanford University School of Medicine
Co-authored papers 14
Richard E Kennedy
University of Alabama at Birmingham (UAB)
Co-authored papers 14
Wendy J Mack
Co-authored papers 13
Jeffrey Kaye
Oregon Center for Aging & Technology
Co-authored papers 12
Gary Cutter
University of Alabama at Birmingham
Co-authored papers 12
Michael W Weiner
University of California San Francisco
Co-authored papers 11
Eric M Reiman
Banner Alzheimer's Institute
Co-authored papers 11
Eric B Larson
University of Washington
Co-authored papers 10
Sonia Pawluczyk
Keck School of Medicine of USC
Co-authored papers 10
Adam L Boxer
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 9
Reisa A Sperling
Brigham and Women's Hospital, Massachusetts General Hospital
Co-authored papers 9
Stephen Salloway
Butler Hospital, and Warren Alpert Medical School of Brown University
Co-authored papers 8
Bruce L Miller
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 8
M-Marsel Mesulam
Northwestern University Feinberg School of Medicine
Co-authored papers 8
Gregory A Jicha
University of Kentucky
Co-authored papers 8
Robert C Green
Brigham and Women's Hospital, Broad Institute Ariadne Labs and Harvard Medical School
Co-authored papers 8
Marilyn Albert
Johns Hopkins University School of Medicine
Co-authored papers 8
Neill R Graff-Radford
Mayo Clinic Florida
Co-authored papers 8
Release 1.2